OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Enhancing these processes involves fine-tuning various factors, including cell line engineering, media formulation, and bioreactor environments. A key goal is to increase antibody yield while reducing production expense